NorthWest Biotherapeutics Inc (NWBO)

[learningcurve2020]

This is likely what’s delaying approval not the skeptics. Probably why they refuse to run more trials too?

“There is a significant subgroup of patients who have lived more than five years,” Dr. Liau says. “But the challenge is trying to determine which patients it may work for and for which patients it doesn’t. Each new discovery gets us closer to improving survival and quality of life for patients facing this devastating disease.”

https://www.uclahealth.org/news/article/beating-brain-cancer-through-vaccines-and-research